APO Research
Talk to an analyst

APO RESEARCH · REPORT

In - Vitro ADME Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global In - Vitro ADME Services Market Outlook and Growth Opportunities 2026

21 December 2025205 pages

Choose your research edition.

Industry ResearchIn - Vitro ADME Services Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal In - Vitro ADME Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal In - Vitro ADME Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In - Vitro ADME Services Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal In - Vitro ADME Services Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global In - Vitro ADME Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for In - Vitro ADME Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In - Vitro ADME Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In - Vitro ADME Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the In - Vitro ADME Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the In - Vitro ADME Services market include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec and IQVIA, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global In - Vitro ADME Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In - Vitro ADME Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In - Vitro ADME Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global In - Vitro ADME Services market.

In - Vitro ADME Services Segment by Company

Charles River

Labcorp

Envigo

Curia

Evotec

Bioduro-Sundia

Lonza

WuXi AppTec

IQVIA

Tecan Group

Pharmaron

Shanghai Medicilon

ChemPartner

Joinn Laboratories

RTI International

Eurofins Scientific

Aragen Life Sciences

Sai Life Sciences

In - Vitro ADME Services Segment by Type

Small Molecules

Biologics

In - Vitro ADME Services Segment by End User

Biopharmaceutical Companies

Government and Academic Institutes

Others

In - Vitro ADME Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global In - Vitro ADME Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the In - Vitro ADME Services key companies, revenue, market share, and recent developments.

3. To split the In - Vitro ADME Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions In - Vitro ADME Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify In - Vitro ADME Services significant trends, drivers, influence factors in global and regions.

6. To analyze In - Vitro ADME Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In - Vitro ADME Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In - Vitro ADME Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In - Vitro ADME Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In - Vitro ADME Services industry.

Chapter 3: Detailed analysis of In - Vitro ADME Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of In - Vitro ADME Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of In - Vitro ADME Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. In - Vitro ADME Services Industry Trends Table 2. In - Vitro ADME Services Industry Drivers Table 3. In - Vitro ADME Services Industry Opportunities and Challenges Table 4. In - Vitro ADME Services Industry Restraints Table 5. Global In - Vitro ADME Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global In - Vitro ADME Services Revenue Share by Company (2021-2026) Table 7. Global In - Vitro ADME Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global In - Vitro ADME Services Key Company Manufacturing Base & Headquarters Table 9. Global In - Vitro ADME Services Company, Product Type & Application Table 10. Global In - Vitro ADME Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global In - Vitro ADME Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Small Molecules Table 15. Significant Companies of Biologics Table 16. Global In - Vitro ADME Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global In - Vitro ADME Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global In - Vitro ADME Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global In - Vitro ADME Services Sales Value Share by Type (2021-2026) Table 20. Global In - Vitro ADME Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biopharmaceutical Companies Table 22. Significant Companies of Government and Academic Institutes Table 23. Significant Companies of Others Table 24. Global In - Vitro ADME Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global In - Vitro ADME Services Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global In - Vitro ADME Services Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global In - Vitro ADME Services Sales Value Share by Application (2021-2026) Table 28. Global In - Vitro ADME Services Sales Value Share by Application (2027-2032) Table 29. Global In - Vitro ADME Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global In - Vitro ADME Services Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global In - Vitro ADME Services Sales Value Share by Region (2021-2026) Table 32. Global In - Vitro ADME Services Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global In - Vitro ADME Services Sales Value Share by Region (2027-2032) Table 34. Global In - Vitro ADME Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global In - Vitro ADME Services Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global In - Vitro ADME Services Sales Value Market Share by Country (2021-2026) Table 37. Global In - Vitro ADME Services Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global In - Vitro ADME Services Sales Value Market Share by Country (2027-2032) Table 39. Charles River Company Information Table 40. Charles River Business Overview Table 41. Charles River In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Charles River In - Vitro ADME Services Product Portfolio Table 43. Charles River Recent Development Table 44. Labcorp Company Information Table 45. Labcorp Business Overview Table 46. Labcorp In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Labcorp In - Vitro ADME Services Product Portfolio Table 48. Labcorp Recent Development Table 49. Envigo Company Information Table 50. Envigo Business Overview Table 51. Envigo In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Envigo In - Vitro ADME Services Product Portfolio Table 53. Envigo Recent Development Table 54. Curia Company Information Table 55. Curia Business Overview Table 56. Curia In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Curia In - Vitro ADME Services Product Portfolio Table 58. Curia Recent Development Table 59. Evotec Company Information Table 60. Evotec Business Overview Table 61. Evotec In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Evotec In - Vitro ADME Services Product Portfolio Table 63. Evotec Recent Development Table 64. Bioduro-Sundia Company Information Table 65. Bioduro-Sundia Business Overview Table 66. Bioduro-Sundia In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bioduro-Sundia In - Vitro ADME Services Product Portfolio Table 68. Bioduro-Sundia Recent Development Table 69. Lonza Company Information Table 70. Lonza Business Overview Table 71. Lonza In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Lonza In - Vitro ADME Services Product Portfolio Table 73. Lonza Recent Development Table 74. WuXi AppTec Company Information Table 75. WuXi AppTec Business Overview Table 76. WuXi AppTec In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. WuXi AppTec In - Vitro ADME Services Product Portfolio Table 78. WuXi AppTec Recent Development Table 79. IQVIA Company Information Table 80. IQVIA Business Overview Table 81. IQVIA In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. IQVIA In - Vitro ADME Services Product Portfolio Table 83. IQVIA Recent Development Table 84. Tecan Group Company Information Table 85. Tecan Group Business Overview Table 86. Tecan Group In - Vitro ADME Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Tecan Group In - Vitro ADME Services Product Portfolio Table 88. Tecan Group Recent Development Table 89. Pharmaron Company Information Table 90. Pharmaron Business Overview Table 91. Pharmaron In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Pharmaron In - Vitro ADME Services Product Portfolio Table 93. Pharmaron Recent Development Table 94. Shanghai Medicilon Company Information Table 95. Shanghai Medicilon Business Overview Table 96. Shanghai Medicilon In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Shanghai Medicilon In - Vitro ADME Services Product Portfolio Table 98. Shanghai Medicilon Recent Development Table 99. ChemPartner Company Information Table 100. ChemPartner Business Overview Table 101. ChemPartner In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. ChemPartner In - Vitro ADME Services Product Portfolio Table 103. ChemPartner Recent Development Table 104. Joinn Laboratories Company Information Table 105. Joinn Laboratories Business Overview Table 106. Joinn Laboratories In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Joinn Laboratories In - Vitro ADME Services Product Portfolio Table 108. Joinn Laboratories Recent Development Table 109. RTI International Company Information Table 110. RTI International Business Overview Table 111. RTI International In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. RTI International In - Vitro ADME Services Product Portfolio Table 113. RTI International Recent Development Table 114. Eurofins Scientific Company Information Table 115. Eurofins Scientific Business Overview Table 116. Eurofins Scientific In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Eurofins Scientific In - Vitro ADME Services Product Portfolio Table 118. Eurofins Scientific Recent Development Table 119. Aragen Life Sciences Company Information Table 120. Aragen Life Sciences Business Overview Table 121. Aragen Life Sciences In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Aragen Life Sciences In - Vitro ADME Services Product Portfolio Table 123. Aragen Life Sciences Recent Development Table 124. Sai Life Sciences Company Information Table 125. Sai Life Sciences Business Overview Table 126. Sai Life Sciences In - Vitro ADME Services Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Sai Life Sciences In - Vitro ADME Services Product Portfolio Table 128. Sai Life Sciences Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. In - Vitro ADME Services Product Image Figure 2. Global In - Vitro ADME Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In - Vitro ADME Services Market Size (2021-2032) & (US$ Million) Figure 4. Global In - Vitro ADME Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Small Molecules Image Figure 8. Biologics Image Figure 9. Global In - Vitro ADME Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global In - Vitro ADME Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global In - Vitro ADME Services Sales Value Share by Type (2021-2032) Figure 12. Biopharmaceutical Companies Image Figure 13. Government and Academic Institutes Image Figure 14. Others Image Figure 15. Global In - Vitro ADME Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global In - Vitro ADME Services Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global In - Vitro ADME Services Sales Value Share by Application (2021-2032) Figure 18. Global In - Vitro ADME Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global In - Vitro ADME Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America In - Vitro ADME Services Sales Value (2021-2032) & (US$ Million) Figure 21. North America In - Vitro ADME Services Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe In - Vitro ADME Services Sales Value (2021-2032) & (US$ Million) Figure 23. Europe In - Vitro ADME Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific In - Vitro ADME Services Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific In - Vitro ADME Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America In - Vitro ADME Services Sales Value (2021-2032) & (US$ Million) Figure 27. South America In - Vitro ADME Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa In - Vitro ADME Services Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa In - Vitro ADME Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt In - Vitro ADME Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecules
  • Biologics
Applications
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
Companies covered
  • Charles River
  • Labcorp
  • Envigo
  • Curia
  • Evotec
  • Bioduro-Sundia
  • Lonza
  • WuXi AppTec
  • IQVIA
  • Tecan Group
  • Pharmaron
  • Shanghai Medicilon
  • ChemPartner
  • Joinn Laboratories
  • RTI International
  • Eurofins Scientific
  • Aragen Life Sciences
  • Sai Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global In - Vitro ADME Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global In - Vitro ADME Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 In - Vitro ADME Services Market Dynamics
  1. 2.1 In - Vitro ADME Services Industry Trends
  2. 2.2 In - Vitro ADME Services Industry Drivers
  3. 2.3 In - Vitro ADME Services Industry Opportunities and Challenges
  4. 2.4 In - Vitro ADME Services Industry Restraints
3 In - Vitro ADME Services Market by Company
  1. 3.1 Global In - Vitro ADME Services Company Revenue Ranking in 2025
  2. 3.2 Global In - Vitro ADME Services Revenue by Company (2021-2026)
  3. 3.3 Global In - Vitro ADME Services Company Ranking (2024-2026)
  4. 3.4 Global In - Vitro ADME Services Company Manufacturing Base and Headquarters
  5. 3.5 Global In - Vitro ADME Services Company Product Type and Application
  6. 3.6 Global In - Vitro ADME Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global In - Vitro ADME Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 In - Vitro ADME Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 In - Vitro ADME Services Market by Type
  1. 4.1 In - Vitro ADME Services Type Introduction
  2. 4.1.1 Small Molecules
  3. 4.1.2 Biologics
  4. 4.2 Global In - Vitro ADME Services Sales Value by Type
  5. 4.2.1 Global In - Vitro ADME Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global In - Vitro ADME Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global In - Vitro ADME Services Sales Value Share by Type (2021-2032)
5 In - Vitro ADME Services Market by Application
  1. 5.1 In - Vitro ADME Services Application Introduction
  2. 5.1.1 Biopharmaceutical Companies
  3. 5.1.2 Government and Academic Institutes
  4. 5.1.3 Others
  5. 5.2 Global In - Vitro ADME Services Sales Value by Application
  6. 5.2.1 Global In - Vitro ADME Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global In - Vitro ADME Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global In - Vitro ADME Services Sales Value Share by Application (2021-2032)
6 In - Vitro ADME Services Regional Value Analysis
  1. 6.1 Global In - Vitro ADME Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global In - Vitro ADME Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global In - Vitro ADME Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global In - Vitro ADME Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America In - Vitro ADME Services Sales Value (2021-2032)
  7. 6.3.2 North America In - Vitro ADME Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe In - Vitro ADME Services Sales Value (2021-2032)
  10. 6.4.2 Europe In - Vitro ADME Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific In - Vitro ADME Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific In - Vitro ADME Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America In - Vitro ADME Services Sales Value (2021-2032)
  16. 6.6.2 South America In - Vitro ADME Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa In - Vitro ADME Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa In - Vitro ADME Services Sales Value Share by Country, 2025 VS 2032
7 In - Vitro ADME Services Country-level Value Analysis
  1. 7.1 Global In - Vitro ADME Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global In - Vitro ADME Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global In - Vitro ADME Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global In - Vitro ADME Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt In - Vitro ADME Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt In - Vitro ADME Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt In - Vitro ADME Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River In - Vitro ADME Services Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp In - Vitro ADME Services Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Envigo
  14. 8.3.1 Envigo Company Information
  15. 8.3.2 Envigo Business Overview
  16. 8.3.3 Envigo In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Envigo In - Vitro ADME Services Product Portfolio
  18. 8.3.5 Envigo Recent Developments
  19. 8.4 Curia
  20. 8.4.1 Curia Company Information
  21. 8.4.2 Curia Business Overview
  22. 8.4.3 Curia In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curia In - Vitro ADME Services Product Portfolio
  24. 8.4.5 Curia Recent Developments
  25. 8.5 Evotec
  26. 8.5.1 Evotec Company Information
  27. 8.5.2 Evotec Business Overview
  28. 8.5.3 Evotec In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Evotec In - Vitro ADME Services Product Portfolio
  30. 8.5.5 Evotec Recent Developments
  31. 8.6 Bioduro-Sundia
  32. 8.6.1 Bioduro-Sundia Company Information
  33. 8.6.2 Bioduro-Sundia Business Overview
  34. 8.6.3 Bioduro-Sundia In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bioduro-Sundia In - Vitro ADME Services Product Portfolio
  36. 8.6.5 Bioduro-Sundia Recent Developments
  37. 8.7 Lonza
  38. 8.7.1 Lonza Company Information
  39. 8.7.2 Lonza Business Overview
  40. 8.7.3 Lonza In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lonza In - Vitro ADME Services Product Portfolio
  42. 8.7.5 Lonza Recent Developments
  43. 8.8 WuXi AppTec
  44. 8.8.1 WuXi AppTec Company Information
  45. 8.8.2 WuXi AppTec Business Overview
  46. 8.8.3 WuXi AppTec In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 WuXi AppTec In - Vitro ADME Services Product Portfolio
  48. 8.8.5 WuXi AppTec Recent Developments
  49. 8.9 IQVIA
  50. 8.9.1 IQVIA Company Information
  51. 8.9.2 IQVIA Business Overview
  52. 8.9.3 IQVIA In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IQVIA In - Vitro ADME Services Product Portfolio
  54. 8.9.5 IQVIA Recent Developments
  55. 8.10 Tecan Group
  56. 8.10.1 Tecan Group Company Information
  57. 8.10.2 Tecan Group Business Overview
  58. 8.10.3 Tecan Group In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Tecan Group In - Vitro ADME Services Product Portfolio
  60. 8.10.5 Tecan Group Recent Developments
  61. 8.11 Pharmaron
  62. 8.11.1 Pharmaron Company Information
  63. 8.11.2 Pharmaron Business Overview
  64. 8.11.3 Pharmaron In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmaron In - Vitro ADME Services Product Portfolio
  66. 8.11.5 Pharmaron Recent Developments
  67. 8.12 Shanghai Medicilon
  68. 8.12.1 Shanghai Medicilon Company Information
  69. 8.12.2 Shanghai Medicilon Business Overview
  70. 8.12.3 Shanghai Medicilon In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Medicilon In - Vitro ADME Services Product Portfolio
  72. 8.12.5 Shanghai Medicilon Recent Developments
  73. 8.13 ChemPartner
  74. 8.13.1 ChemPartner Company Information
  75. 8.13.2 ChemPartner Business Overview
  76. 8.13.3 ChemPartner In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ChemPartner In - Vitro ADME Services Product Portfolio
  78. 8.13.5 ChemPartner Recent Developments
  79. 8.14 Joinn Laboratories
  80. 8.14.1 Joinn Laboratories Company Information
  81. 8.14.2 Joinn Laboratories Business Overview
  82. 8.14.3 Joinn Laboratories In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Joinn Laboratories In - Vitro ADME Services Product Portfolio
  84. 8.14.5 Joinn Laboratories Recent Developments
  85. 8.15 RTI International
  86. 8.15.1 RTI International Company Information
  87. 8.15.2 RTI International Business Overview
  88. 8.15.3 RTI International In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 RTI International In - Vitro ADME Services Product Portfolio
  90. 8.15.5 RTI International Recent Developments
  91. 8.16 Eurofins Scientific
  92. 8.16.1 Eurofins Scientific Company Information
  93. 8.16.2 Eurofins Scientific Business Overview
  94. 8.16.3 Eurofins Scientific In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Eurofins Scientific In - Vitro ADME Services Product Portfolio
  96. 8.16.5 Eurofins Scientific Recent Developments
  97. 8.17 Aragen Life Sciences
  98. 8.17.1 Aragen Life Sciences Company Information
  99. 8.17.2 Aragen Life Sciences Business Overview
  100. 8.17.3 Aragen Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aragen Life Sciences In - Vitro ADME Services Product Portfolio
  102. 8.17.5 Aragen Life Sciences Recent Developments
  103. 8.18 Sai Life Sciences
  104. 8.18.1 Sai Life Sciences Company Information
  105. 8.18.2 Sai Life Sciences Business Overview
  106. 8.18.3 Sai Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sai Life Sciences In - Vitro ADME Services Product Portfolio
  108. 8.18.5 Sai Life Sciences Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst